DocMorris Valuation
| DOCM Stock | 5.07 0.18 3.43% |
At this time, the firm appears to be overvalued. DocMorris AG shows a prevailing Real Value of USD4.55 per share. The current price of the firm is USD5.07. Our model computes the value of DocMorris AG from reviewing the firm fundamentals such as Current Valuation of 377.52 M, profit margin of (0.11) %, and Operating Margin of (0.1) % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting DocMorris' valuation include:
Price Book 0.6188 | Enterprise Value | Enterprise Value Ebitda (9.29) | Price Sales 0.2402 | Enterprise Value Revenue 0.3554 |
Overvalued
Today
Please note that DocMorris' price fluctuation is relatively risky at this time. Calculation of the real value of DocMorris AG is based on 3 months time horizon. Increasing DocMorris' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the DocMorris stock is determined by what a typical buyer is willing to pay for full or partial control of DocMorris AG. Since DocMorris is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DocMorris Stock. However, DocMorris' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.07 | Real 4.55 | Hype 5.06 | Naive 5.21 |
The intrinsic value of DocMorris' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence DocMorris' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of DocMorris AG helps investors to forecast how DocMorris stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of DocMorris more accurately as focusing exclusively on DocMorris' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use DocMorris' intrinsic value based on its ongoing forecasts of DocMorris' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against DocMorris' closest peers.
DocMorris Cash |
|
DocMorris Total Value Analysis
DocMorris AG is currently anticipated to have takeover price of 377.52 M with market capitalization of 255.15 M, debt of 312.21 M, and cash on hands of 95.37 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the DocMorris fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
377.52 M | 255.15 M | 312.21 M | 95.37 M |
DocMorris Investor Information
About 17.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.62. Some equities with similar Price to Book (P/B) outperform the market in the long run. DocMorris AG recorded a loss per share of 4.58. The entity last dividend was issued on the 22nd of November 2018. The firm had 593:292 split on the 13th of May 2025. Based on the key indicators related to DocMorris' liquidity, profitability, solvency, and operating efficiency, DocMorris AG is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.DocMorris Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. DocMorris has an asset utilization ratio of 130.7 percent. This indicates that the Company is making USD1.31 for each dollar of assets. An increasing asset utilization means that DocMorris AG is more efficient with each dollar of assets it utilizes for everyday operations.DocMorris Profitability Analysis
Based on DocMorris' profitability indicators, DocMorris AG may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in March. Profitability indicators assess DocMorris' ability to earn profits and add value for shareholders.Net Loss | First Reported 2009-12-31 | Previous Quarter -25.2 M | Current Value -61.6 M | Quarterly Volatility 30.8 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.13 | 0.19 |
|
|
For DocMorris profitability analysis, we use financial ratios and fundamental drivers that measure the ability of DocMorris AG to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well DocMorris utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between DocMorris's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of DocMorris over time as well as its relative position and ranking within its peers.
DocMorris Earnings per Share Projection vs Actual
By analyzing DocMorris' earnings estimates, investors can diagnose different trends across DocMorris' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for DocMorris AG is based on EPS before non-recurring items and includes expenses related to employee stock options.DocMorris Ownership Allocation
DocMorris holds a total of 48.6 Million outstanding shares. DocMorris AG shows significant amount of outstanding shares owned by insiders and institutional investors .Since such a large part of the company is not owned by regular investors, we recommend to check if there were significant buying or selling the DocMorris AG stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.DocMorris Profitability Analysis
The company reported the revenue of 1.02 B. Net Loss for the year was (97.25 M) with profit before overhead, payroll, taxes, and interest of 230.27 M.About DocMorris Valuation
Our relative valuation model uses a comparative analysis of DocMorris. We calculate exposure to DocMorris's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of DocMorris's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 249 M | 174.7 M | |
| Pretax Profit Margin | (0.12) | (0.11) | |
| Operating Profit Margin | (0.12) | (0.11) | |
| Net Loss | (0.11) | (0.10) | |
| Gross Profit Margin | 0.19 | 0.13 |
Additional Tools for DocMorris Stock Analysis
When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.